These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3871985)

  • 1. Clavulanate-potentiated amoxycillin: activity in vitro and bioavailability in the dog.
    Bywater RJ; Palmer GH; Buswell JF; Stanton A
    Vet Rec; 1985 Jan; 116(2):33-6. PubMed ID: 3871985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clavulanate-potentiated amoxycillin: in vitro antibacterial activity and oral bioavailability in calves.
    Soback S; Bor A; Kurtz B; Paz R; Ziv G
    J Vet Pharmacol Ther; 1987 Jun; 10(2):105-13. PubMed ID: 3302313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of clavulanate-potentiated amoxycillin in experimental and clinical skin infections.
    Bywater RJ; Hewett GR; Marshall AB; West B
    Vet Rec; 1985 Feb; 116(7):177-9. PubMed ID: 3887742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor.
    Smith BR; LeFrock JL
    Drug Intell Clin Pharm; 1985 Jun; 19(6):415-20. PubMed ID: 3891282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
    Livermore DM; Seetulsingh P
    J Antimicrob Chemother; 1991 Jun; 27(6):761-7. PubMed ID: 1669013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
    Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
    Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR; Spangler SK; Appelbaum PC
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro activity of amoxycillin with clavulanic acid against clinically significant bacteria. A multicentre study.
    Van den Ende J; Gricius ME; De Klerk HC; Neiteler BF; Forder AA; Venter L; Hallett AF; Koornhof HJ; Robinson R; Van Rensburg AJ; Lindeque KP
    S Afr Med J; 1982 Jul; 62(5 Spec No):5A-8A. PubMed ID: 6979805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1978 Mar; 13(3):389-93. PubMed ID: 122520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of campylobacter isolates to clavulanate-potentiated amoxycillin.
    Corbel MJ; Ibrahim ME; Gill KP
    Vet Rec; 1984 Nov; 115(18):465. PubMed ID: 6568786
    [No Abstract]   [Full Text] [Related]  

  • 11. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of amoxycillin/clavulanate against beta-lactamase-producing Escherichia coli and Klebsiella spp.
    Roy C; Segura C; Torrellas A; Reig R; Teruel D; Hermida M
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():41-7. PubMed ID: 2691485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bactericidal effects of amoxycillin/clavulanic acid and ticarcillin/clavulanic acid in in-vitro kinetic models.
    White AR; Stokes DH; Slocombe B; Sutherland R
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():227-32. PubMed ID: 3980328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-lactamase evaluation of the amoxycillin-clavulanate association.
    Novelli A; Reali EF; Fallani S; Periti P
    Drugs Exp Clin Res; 1989; 15(4):151-4. PubMed ID: 2505995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
    Cooper CE; Slocombe B; White AR
    J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.
    Seetulsingh PS; Hall LM; Livermore DM
    J Antimicrob Chemother; 1991 Jun; 27(6):749-59. PubMed ID: 1938685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential sensitivities to amoxycillin/clavulanate and amoxycillin in general practice urinary infections.
    Brumfitt W; Hamilton-Miller JM
    Lancet; 1983 Sep; 2(8349):566. PubMed ID: 6136712
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic interaction of amoxycillin and clavulanic acid against 132 beta-lactamase positive Haemophilus isolates: a comparison with some other oral agents.
    Lapointe JR; Lavallée C
    J Antimicrob Chemother; 1987 Jan; 19(1):49-58. PubMed ID: 3494009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes.
    Fuglesang JE; Bergan T
    Infection; 1983; 11(6):329-35. PubMed ID: 6365790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
    Bourgault AM; Lamothe F
    J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.